Wilms' tumor 1 gene in hematopoietic malignancies: clinical implications and future directions.

Luo, Ping; Jing, Wei; Yi, Kezhen; Wu, Sanyun; Zhou, Fuling

Luo, Ping; Jing, Wei; Yi, Kezhen; Wu, Sanyun; Zhou, Fuling.

Afiliação

Luo P; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jing W; Department of Clinical Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yi K; Department of Clinical Laboratory Medicine & Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wu S; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhou F; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Leuk Lymphoma ; 61(9): 2059-2067, 2020 09.

Article em En | MEDLINE | ID: mdl-32401109

Assuntos

Neoplasias Hematológicas; Leucemia Mieloide Aguda; Síndromes Mielodisplásicas; Tumor de Wilms; Neoplasias Hematológicas/diagnóstico; Neoplasias Hematológicas/genética; Humanos; Neoplasia Residual/genética; Proteínas WT1/genética

Palavras-chave

AML; Hematopoietic malignancies; MDS; MRD; WT1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Tumor de Wilms / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google